CPD Accreditation – Directory listing
The Pharmacy Consulting Limited team are excited to announce that we are now listed on the directory on the CPD website as one of their accredited training providers!
The Pharmacy Consulting Limited team are excited to announce that we are now listed on the directory on the CPD website as one of their accredited training providers!
The next generation will be smoke-free as the Tobacco and Vapes Bill was granted Royal Assent on 29th April 2026. This deliveries an historic step towards a smoke-free UK and protecting people from the harms of tobacco by making it illegal to sell tobacco to anyone born on or after 1st January 2009.
The latest announcement from Community Pharmacy England marks another significant milestone in what is becoming an increasingly unstable period for the UK medicines supply chain. With 204 price concessions agreed for April — surpassing the previous record of 201 concessions in March — the sector is witnessing sustained and escalating pricing volatility at a scale rarely seen before.
NHS England spoke at the recent Making and Distributing Pharmaceuticals conference in a joint presentation with GS1. The presentation focused on the NHS’s use of barcodes and the importance of them being consistently applied.
There was a lot of discussion around the use of AI in GxP from some of the experts in the field, which was exceptionally interesting and inciteful.
Are you an internal RP that has limited time or resources to support your own CPD? Have you considered an RP forum? This blog discusses some of the benefits.
For most pharmaceutical companies, Transport is no longer a singular operation—it’s a chain of outsourced activities spanning freight forwarders, airlines, agents, depots, licenced facilities, last‑mile carriers, and specialist logistics providers.
The Pharmacy Consulting Limited team are extremely pleased to announce that we have today received out CPD Accreditation from CPD Standards!
Read all about the impact of Artificial Intelligence on Pharmacies. A new statement has been published by the General Pharmaceutical Council (20th April 2026)